Development of a CYP2C19 Genotype Guided Dosing Algorithm for Voriconazole

被引：0
|
作者：
Mangal, Naveen [1 ]
Hamadeh, Issam [2 ]
Samant, Tanay [1 ]
Schmidt, Stephan [1 ]
机构：
[1] Univ Florida, Coll Pharm, Ctr Pharmacometr & Syst Pharmacol, Orlando, FL USA
[2] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-031
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [1] A CYP2C19 genotype guided dosing approach for optimizing voriconazole in patients with IFIs.
    Hamadeh, Issam
    Schmidt, S.
    Mangal, N.
    Hiemenz, J.
    Langaee, T.
    Peloquin, C.
    Wiggins, L.
    Arp, C.
    Kinkler, K.
    Johnson, J.
    PHARMACOTHERAPY, 2014, 34 (10): : E261 - E261
  • [2] A PILOT STUDY TO EVALUATE THE APPROPRIATENESS OF THE CYP2C19 PHENOTYPE-GUIDED VORICONAZOLE DOSING REGIMEN ACCORDING TO CYP2C19 PHENOTYPE.
    Lee, S.
    Kim, Y.
    Kim, E.
    Hwang, I.
    Kim, H.
    Rhee, S.
    Cho, J.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S54 - S54
  • [3] A PILOT STUDY TO EVALUATE THE APPROPRIATENESS OF THE CYP2C19 PHENOTYPE-GUIDED VORICONAZOLE DOSING REGIMEN ACCORDING TO CYP2C19 PHENOTYPE.
    Lee, S.
    Kim, Y.
    Kim, E.
    Hwang, I.
    Kim, H.
    Rhee, S.
    Cho, J.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S16 - S16
  • [4] Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole
    Klomp, Sylvia D.
    Veringa, Anette
    Alffenaar, Jan-Willem C.
    de Boer, Mark G. J.
    Span, Lambert F. R.
    Guchelaar, Henk-Jan
    Swen, Jesse J.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (07):
  • [5] CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis
    Patel, Jai N.
    Robinson, Myra M.
    Hamadeh, Issam
    Shahid, Zainab
    Symanowski, James T.
    Plesca, Dragos
    Croom, Margaret
    Trivedi, Jigar
    Steuerwald, Nury M.
    Avalos, Belinda R.
    Copelan, Edward A.
    BLOOD, 2016, 128 (22)
  • [6] A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic Analysis
    Kim, Yun
    Rhee, Su-jin
    Park, Wan Beom
    Yu, Kyung-Sang
    Jang, In-Jin
    Lee, And Seunghwan
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02):
  • [7] Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant
    Patel, Jai N.
    Hamadeh, Issam S.
    Robinson, Myra
    Shahid, Zainab
    Symanowski, James
    Steuerwald, Nury
    Hamilton, Alicia
    Reese, Emily S.
    Plesca, Dragos C.
    Arnall, Justin
    Taylor, Margaret
    Trivedi, Jigar
    Grunwald, Michael R.
    Gerber, Jonathan
    Ghosh, Nilanjan
    Avalos, Belinda
    Copelan, Edward
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (03) : 571 - 579
  • [8] Voriconazole-induced hyponatraemia associated with homozygous CYP2C19*2 genotype
    Ho, Sharon
    Rawlins, Matthew
    Ingram, Paul
    Boan, Peter
    JOURNAL OF CHEMOTHERAPY, 2017, 29 (05) : 325 - 326
  • [9] CYP2C19 Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole
    Weiss, Johanna
    ten Hoevel, Magdalena Maria
    Burhenne, Juergen
    Walter-Sack, Ingeborg
    Hoffmann, Michael Marcus
    Rengelshausen, Jens
    Haefeli, Walter E.
    Mikus, Gerd
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (02): : 196 - 204
  • [10] Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections
    Hamadeh, Issam S.
    Klinker, Kenneth P.
    Borgert, Samuel J.
    Richards, Ashley I.
    Li, Wenhui
    Mangal, Naveen
    Hiemenz, John W.
    Schmidt, Stephan
    Langaee, Taimour Y.
    Peloquin, Charles A.
    Johnson, Julie A.
    Cavallari, Larisa H.
    PHARMACOGENETICS AND GENOMICS, 2017, 27 (05): : 190 - 196
12345